# INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM"

> **NCT06886399** · PHASE2 · COMPLETED · sponsor: **Industrial Microbiology LLP** · enrollment: 210 (actual)

## Conditions studied

- Intestinal Infections
- Dysbacteriosis

## Interventions

- **DRUG:** "AS-Probionorm"

## Key facts

- **NCT ID:** NCT06886399
- **Lead sponsor:** Industrial Microbiology LLP
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-22
- **Primary completion:** 2024-08-11
- **Final completion:** 2024-08-11
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06886399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06886399, "INVESTIGATION of the EFFICACY and SAFETY of the DRUG "AS-PROBIONORM"". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT06886399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*